New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
07:55 EDTCVS, ESRX, CTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
News For CTRX;ESRX;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 29, 2015
11:21 EDTESRXMorgan Stanley reports 5% passive stake in Express Scripts
Subscribe for More Information
10:23 EDTCTRXOptions with decreasing implied volatility
Options with decreasing implied volatility: THC CYH HCA BBBY BBRY BKS NKE OVTI ACN CTRX
June 25, 2015
10:02 EDTCTRXCatamaran and Health New England announces partnership reduced readmissions
Catamaran and Health New England announced one-year results from Catamaran's Hospital Transition Program, which dramatically reduced HNE's hospital readmission rates and increased medication adherence. HNE and Catamaran collaborated on a program that enhanced data sharing and communication between the health plan, hospital and PBM, and enabled a more diligent and comprehensive level of education, monitoring and intervention where appropriate with patients once released to the ambulatory setting. One year after implementing the program, 30-day same-cause readmissions in the intervention group were more than 70 percent below that of an equally-matched control group, while all-cause readmissions decreased by more than 50 percent. Additionally, 44 percent of the program's intervention calls to patients falling out of appropriate adherence (more than two days late refilling a prescription) resulted in a member medication refill within seven days.
05:48 EDTESRXStocks with implied volatility movement; SDS ESRX
Stocks with implied volatility movement; UltraShort S&P500 ProShares (SDS) 28, Express Scripts (ESRX) 27 according to iVolatility.
June 24, 2015
14:13 EDTESRXExpress Scripts July weekly volatility elevated as shares near record high
Subscribe for More Information
10:00 EDTCTRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Sell from Neutral at Goldman... Catamaran (CTRX) downgraded to Neutral from Buy at UBS... Citi (C) downgraded to Hold from Buy at Deutsche Bank... Esperion (ESPR) downgraded to Neutral from Outperform at Credit Suisse... Fortinet (FTNT) downgraded to Neutral from Buy at Citi... General Motors (GM) downgraded to Neutral from Buy at Goldman... Goldman Sachs (GS) downgraded to Hold from Buy at Deutsche Bank... IBERIABANK (IBKC) downgraded to Neutral from Outperform at Baird... Independent Bank (INDB) downgraded to Underperform from Neutral at Baird... Inphi (IPHI) downgraded to Market Perform from Outperform at Northland... MoneyGram (MGI) downgraded to Neutral from Outperform at Macquarie... Sensata (ST) downgraded to Hold from Buy at Cross Research... Teradyne (TER) downgraded to Buy from Conviction Buy at Goldman... Alcobra (ADHD) downgraded to Hold from Speculative Buy at WBB Securities.
08:33 EDTCVSCVS Health enters into four new clinical affiliations
CVS Health has entered into new clinical affiliations with Sutter Health in California, Millennium Physician Group in Florida, Bryan Health Connect in Nebraska and Mount Kisco Medical Group, PC in New York. Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations.
05:42 EDTCTRXCatamaran downgraded to Neutral from Buy at UBS
UBS downgraded Catamaran (CTRX) to Neutral saying the stock new fully reflects the UnitedHealth (UNH) takeover deal terms. UnitedHealth management in recent meetings expressed confidence that its pending $61.50 per share purchase of Catamaran will still close in the second half of 2015, UBS tells investors.
June 23, 2015
10:54 EDTCVSCVS Health expects to complete $5B in share repurchases in 2015
10:40 EDTCVSCVS Health sees Omnicare transaction closing by end of year
Subscribe for More Information
10:31 EDTCVSCVS Health names Norman de Greve as Chief Marketing Officer, effective July 15
CVS Health announced that Norman de Greve will join CVS Health as Chief Marketing Officer, effective July 15. In this role, de Greve will be accountable for marketing strategy across the enterprise. He is currently the President of the Boston and Detroit offices of DigitasLBi.
June 22, 2015
08:16 EDTESRX, CTRXAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
June 19, 2015
16:24 EDTCVSStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
11:17 EDTESRXExpress Scripts calls active amid bid speculation
Subscribe for More Information
June 18, 2015
10:01 EDTCVS, ESRXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTCVS, ESRXLeerink to hold a roundtable
Subscribe for More Information
June 17, 2015
16:22 EDTCVSCVS Health initiated with an Outperform at Oppenheimer
Subscribe for More Information
16:20 EDTESRXExpress Scripts initiated with a Perform at Oppenheimer
Subscribe for More Information
09:43 EDTESRXExpress Scripts management to meet with Deutsche Bank
Meeting to be held in New York on June 17 hosted by Deutsche Bank.
June 16, 2015
08:41 EDTCVSCVS Health deal 'extremely attractive,' says SunTrust
After CVS Health (CVS) agreed to buy Target's (TGT) pharmacies/clinics, SunTrust says that CVS.will benefit strategically and financially from the deal. The firm believes that the deal is capital efficient, provides CVS with an immediate and noticeable presence in several key markets and further rounds out CVS' presence in other geographies. It keeps a Buy rating on the stock.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use